ADVERTISEMENT
of Justice represents FDA in these matters, and FDA is continuing to review the safety data for mifepristone.”
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving continue reading …
ADVERTISEMENT